Search - Université de Rennes Access content directly

Filter your results

27 Results
authFullName_s : Eric Berger
Image document

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

David-Axel Laplaud , Romain Casey , Laetitia Barbin , Marc Debouverie , Jerome de Sèze et al.
Neurology, 2019, 93 (7), pp.e635-e646. ⟨10.1212/WNL.0000000000007938⟩
Journal articles inserm-02289153v1

Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France

Sandra Vukusic , Fabien Rollot , Romain Casey , Julie Pique , Romain Marignier et al.
JAMA neurology, 2020, 77 (1), pp.94. ⟨10.1001/jamaneurol.2019.2670⟩
Journal articles hal-02302155v1

Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

C. Lebrun , S. Vukusic , V. Abadie , C. Achour , F. Ader et al.
Revue Neurologique, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Journal articles hal-02546158v1

Formes cavitaires de sclérose en plaques : étude multicentrique sur vingt patients [Cavitary lesions in multiple sclerosis: multicenter study on twenty patients].

A. Corlobé , Didier Renard , C Goizet , Eric Berger , L Rumbach et al.
Revue Neurologique, 2013, 169 (12), pp.965-9. ⟨10.1016/j.neurol.2013.02.010⟩
Journal articles inserm-01576397v1
Image document

Determinants of Therapeutic Lag in Multiple Sclerosis

Izanne Roos , Emmanuelle Leray , Federico Frascoli , Romain Casey , J William L Brown et al.
Multiple Sclerosis Journal, 2021, 27 (12), pp.1838-1851. ⟨10.1177/1352458520981300⟩
Journal articles hal-03223056v1

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system

Camille Sabathé , Romain Casey , Sandra Vukusic , Emmanuelle Leray , Guillaume Mathey et al.
Multiple Sclerosis Journal, 2023, 29 (2), pp.236-247. ⟨10.1177/13524585221139156⟩
Journal articles hal-04086418v1
Image document

Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome

Christine Lebrun-Frénay , Fabien Rollot , Lydiane Mondot , Helene Zephir , Celine Louapre et al.
JAMA Network Open, 2021, 4 (10), pp.e2128271. ⟨10.1001/jamanetworkopen.2021.28271⟩
Journal articles hal-03414579v1
Image document

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

Laetitia Barbin , Chloé Rousseau , Natacha Jousset , Romain Casey , Marc Debouverie et al.
Neurology, 2016, 86 (8), pp.771-778. ⟨10.1212/WNL.0000000000002395⟩
Journal articles hal-01299977v1

Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal

Fabien Rollot , Justine Couturier , Romain Casey , Sandrine Wiertlewski , Marc Debouverie et al.
Neurotherapeutics, 2022, 19 (2), pp.476-490. ⟨10.1007/s13311-022-01202-1⟩
Journal articles hal-03594074v1

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Xavier Ayrignac , Clarisse Carra Dallière , Nicolas Menjot de Champfleur , Christian Denier , Patrick Aubourg et al.
Brain - A Journal of Neurology , 2015, 138 (Pt 2), pp.284-92. ⟨10.1093/brain/awu353⟩
Journal articles hal-01138578v1

Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference

Antoine Gavoille , Fabien Rollot , Romain Casey , Marc Debouverie , Emmanuelle Le Page et al.
Neurology, 2023, 100 (12), pp.e1296-e1308. ⟨10.1212/WNL.0000000000206774⟩
Journal articles hal-03963580v1

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

Izanne Roos , Charles Malpas , Emmanuelle Leray , Romain Casey , Dana Horakova et al.
Neurology, 2022, 99 (17), pp.e1926-e1944. ⟨10.1212/WNL.0000000000201029⟩
Journal articles hal-03776286v1

Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study

D. A. Laplaud , L. Barbin , Chloé Rousseau , N. Jousset , Romain Casey et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.62--63
Journal articles hal-01259392v1
Image document

Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis

Alexandra Garcia , Emilie Dugast , Sita Shah , Jérémy Morille , Christine Lebrun-Frenay et al.
Neurology Neuroimmunology & Neuroinflammation, 2023, 10 (3), pp.e200091. ⟨10.1212/NXI.0000000000200091⟩
Journal articles hal-04064282v1
Image document

Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study

Sarah Wilson , Floriane Calocer , Fabien Rollot , Mathieu Fauvernier , Laurent Remontet et al.
The Lancet Regional Health - Europe, 2023, 24, pp.100542. ⟨10.1016/j.lanepe.2022.100542⟩
Journal articles hal-03875120v1
Image document

Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament-light chain in multiple sclerosis

Audrey Gauthier , Sébastien Viel , Magali Perret , Guillaume Brocard , Romain Casey et al.
Annals of Clinical and Translational Neurology, 2021, 8 (5), pp.1141-1150. ⟨10.1002/acn3.51355⟩
Journal articles hal-03216866v1
Image document

Untreated patients with multiple sclerosis: A study of French expert centers

Xavier Moisset , Audrey-Anne Fouchard , Bruno Pereira , Frederic Taithe , Guillaume Mathey et al.
European Journal of Neurology, 2021, 28 (6), pp.2026-2036. ⟨10.1111/ene.14790⟩
Journal articles hal-03188971v1
Image document

The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

Johanna Andersen , Sifat Sharmin , Mathilde Lefort , Nils Koch-Henriksen , Finn Sellebjerg et al.
Multiple Sclerosis and Related Disorders, 2021, 53, pp.103012. ⟨10.1016/j.msard.2021.103012⟩
Journal articles hal-03268539v1

Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients

G. Balloy , Jean Pelletier , L. Suchet , C. Lebrun , M. Cohen et al.
Journal of Neurology, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Journal articles hal-02066038v1
Image document

Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study

Caroline Papeix , Giovanni Castelnovo , Emmanuelle Leray , Marc Coustans , Pierre Levy et al.
Neurology and Therapy, 2022, ⟨10.1007/s40120-022-00334-y⟩
Journal articles hal-03608016v1

Delay from treatment start to full effect of immunotherapies for multiple sclerosis

Izanne Roos , Emmanuelle Leray , Federico Frascoli , Romain Casey , J William L Brown et al.
Brain - A Journal of Neurology , 2020, 143 (9), pp.2742-2756. ⟨10.1093/brain/awaa231⟩
Journal articles hal-02955197v1
Image document

New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions

Stephane Kremer , Salem Hannoun , Fabrice Bonneville , Francoise Durand-Dubief , Thomas Tourdias et al.
Journal de Neuroradiologie / Journal of Neuroradiology, 2020, 47 (4), pp.250-258. ⟨10.1016/j.neurad.2020.01.083⟩
Journal articles hal-02570313v1

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

Sifat Sharmin , Mathilde Lefort , Johanna Balslev Andersen , Emmanuelle Leray , Dana Horakova et al.
CNS Drugs, 2021, 35 (11), pp.1217-1232. ⟨10.1007/s40263-021-00860-7⟩
Journal articles hal-03367246v1
Image document

Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis

Sophie Mathais , Xavier Moisset , Bruno Pereira , Frederic Taithe , Jonathan Ciron et al.
Neurotherapeutics, 2021, 18 (1), pp.378-386. ⟨10.1007/s13311-020-00926-2⟩
Journal articles hal-02995967v1
Image document

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study

Emmanuelle Leray , Sandra Vukusic , Marc Debouverie , Michel Clanet , Bruno Brochet et al.
PLoS ONE, 2015, 10 (7), pp.1-12. ⟨10.1371/journal.pone.0132033⟩
Journal articles hal-01201656v1

Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study

Sandra Vukusic , Iuliana Ionescu , Catherine Cornu , Nadine Bossard , Françoise Durand-Dubief et al.
Multiple Sclerosis Journal, 2021, 27 (9), pp.1458-1463. ⟨10.1177/1352458520978218⟩
Journal articles hal-03101890v1

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS

Caroline Lavie , Fabien Rollot , Françoise Durand-Dubief , Romain Marignier , Iuliana Ionescu et al.
Multiple Sclerosis Journal, 2019, 25 (4), pp.591-600. ⟨10.1177/1352458518763080⟩
Journal articles hal-02158735v1